Cited by 1,125Animal Genetics and ReproductionCRISPR and Genetic EngineeringVirus-based gene therapy research

Efficient in vivo manipulation of mouse genomic sequences at the zygote stage.

Open access
Lakso, M, Pichel, J G, Gorman, J R, Sauer, B, Okamoto, Y, Lee, E, Alt, F W, Westphal, H·1996·Proceedings of the National Academy of Sciences

Abstract

We describe a transgenic mouse line carrying the cre transgene under the control of the adenovirus EIIa promoter that targets expression of the Cre recombinase to the early mouse embryo. To assess the ability of this recombinase to excise loxP-flanked DNA sequences at early stages of development, we bred EIIa-cre transgenic mice to two different mouse lines carrying loxP-flanked target sequences: (i) a strain with a single gene-targeted neomycin resistance gene flanked by 1oxP sites and (ii) a transgenic line carrying multiple transgene copies with internal loxP sites. Mating either of these loxP-carrying mouse lines to EIIa-cre mice resulted in first generation progeny in which the loxP-flanked sequences had been efficiently deleted from all tissues tested, including the germ cells. Interbreeding of these first generation progeny resulted in efficient germ-line transmission of the deletion to subsequent generations. These results demonstrate a method by which loxP-flanked DNA sequences can be efficiently deleted in the early mouse embryo. Potential applications of this approach are discussed, including reduction of multicopy transgene loci to produce single-copy transgenic lines and introduction of a variety of subtle mutations into the line.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.93.12.5860

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Tamoxifen-mediated CX3CR1CreER(Litt) expression increases Sholl intersections in pups (P7-P9).

    “Tamoxifen-mediated Cre-recombinase expression under the promoter CX3CR1 (CX3CR1CreER(Litt)) has been shown to reduce IBA1+ microglia density in pups (P7-P9), while leading to increased IBA1+ microglia volume and Sholl intersections8.”

    From Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects in microglia (2026) · cites this paper as [8]

    The indexed Abstract (page not specified) describes Cre expression under the adenovirus EIIa promoter and deletion of loxP-flanked sequences in early mouse embryos. Searches for CX3CR1CreER, tamoxifen, microglia, and Sholl intersections found no passage addressing the claimed increase in Sholl intersections in P7–P9 pups. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • The irregular microglial number and phenotype caused by early postnatal induction of CX3CR1CreER(Litt) normalize by adulthood.

    “While the irregular microglial number and phenotype had normalized by adulthood”

    From Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects in microglia (2026) · cites this paper as [8]

    The indexed Abstract describes EIIa-cre-mediated deletion of loxP-flanked sequences in early mouse embryos, not microglia. Searches for microglial normalization and CX3CR1CreER(Litt) found no passage addressing either; the available copy links to the full text but does not provide the potentially decisive body text. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • Tamoxifen-mediated CX3CR1CreER(Litt) expression increases IBA1+ microglia volume in pups (P7-P9).

    “Tamoxifen-mediated Cre-recombinase expression under the promoter CX3CR1 (CX3CR1CreER(Litt)) has been shown to reduce IBA1+ microglia density in pups (P7-P9), while leading to increased IBA1+ microglia volume and Sholl intersections8.”

    From Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects in microglia (2026) · cites this paper as [8]

    The indexed Abstract describes EIIa-promoter Cre activity in early mouse embryos, not tamoxifen-mediated CX3CR1CreER activity or microglia in P7–P9 pups. Searches for CX3CR1CreER, IBA1, microglia volume, and Sholl intersections found no relevant passage. Our copy links to a PDF but does not include its body text, so the claim cannot be verified from it. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • Early postnatal induction of CX3CR1CreER(Litt) causes DNA damage in microglia during the early postnatal period.

    “The authors found a lower microglial density, an altered phenotype, upregulation of their phagocytic function, and DNA damage in the Cre+ microglia of the developing brain.”

    From Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects in microglia (2026) · cites this paper as [8]

    The Abstract (page not supplied) describes EIIa-Cre-mediated deletion of loxP-flanked sequences in early mouse embryos, not early postnatal CX3CR1CreER(Litt) induction. Searches for CX3CR1CreER(Litt), microglia, DNA damage, density, and phagocytic function found no relevant passage in our copy; the article body is represented only by a PDF link. (LLM, conf=0.75)

    Experimental — accuracy not yet measured
  • Tamoxifen-mediated CX3CR1CreER(Litt) expression decreases the number of proliferating microglia in the early postnatal period.

    “It has been shown that tamoxifen-mediated Cre-recombinase expression (CX3CR1CreER(Litt)) decreases the number of proliferating microglia, thereby suggesting decreased proliferation of early postnatal microglia, as well as induces DNA damage in the early postnatal period8.”

    From Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects in microglia (2026) · cites this paper as [8]

    The Abstract (page not provided) describes EIIa-promoter-driven Cre recombinase activity in early mouse embryos. Searches for CX3CR1CreER(Litt), tamoxifen, microglial proliferation, and DNA damage found no passage addressing the claimed effect; the indexed copy shows an abstract and references but not the article body. (LLM, conf=0.73)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 17

  1. Araki K., Araki M., Miyazaki J., Vassalli P. Site-specific recombination of a transgene in fertilized eggs by transient expression of Cre recombinase. Proc Natl Acad Sci U S A. 1995 Jan 3;92(1):160–164. doi: 10.1073/pnas.92.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  2. Baubonis W., Sauer B. Genomic targeting with purified Cre recombinase. Nucleic Acids Res. 1993 May 11;21(9):2025–2029. doi: 10.1093/nar/21.9.2025. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  3. Dooley T. P., Miranda M., Jones N. C., DePamphilis M. L. Transactivation of the adenovirus EIIa promoter in the absence of adenovirus E1A protein is restricted to mouse oocytes and preimplantation embryos. Development. 1989 Dec;107(4):945–956. doi: 10.1242/dev.107.4.945. [DOI] [PubMed] [Google Scholar] · DOI
  4. Gu H., Marth J. D., Orban P. C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1994 Jul 1;265(5168):103–106. doi: 10.1126/science.8016642. [DOI] [PubMed] [Google Scholar] · DOI
  5. Kogan S. C., Doherty M., Gitschier J. An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med. 1987 Oct 15;317(16):985–990. doi: 10.1056/NEJM198710153171603. [DOI] [PubMed] [Google Scholar] · DOI
  6. Kühn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 1995 Sep 8;269(5229):1427–1429. doi: 10.1126/science.7660125. [DOI] [PubMed] [Google Scholar] · DOI
  7. Lakso M., Sauer B., Mosinger B., Jr, Lee E. J., Manning R. W., Yu S. H., Mulder K. L., Westphal H. Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6232–6236. doi: 10.1073/pnas.89.14.6232. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  8. Mahon K. A., Chepelinsky A. B., Khillan J. S., Overbeek P. A., Piatigorsky J., Westphal H. Oncogenesis of the lens in transgenic mice. Science. 1987 Mar 27;235(4796):1622–1628. doi: 10.1126/science.3029873. [DOI] [PubMed] [Google Scholar] · DOI
  9. Mansour S. L., Thomas K. R., Capecchi M. R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature. 1988 Nov 24;336(6197):348–352. doi: 10.1038/336348a0. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  10. Nakamura T., Mahon K. A., Miskin R., Dey A., Kuwabara T., Westphal H. Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice. New Biol. 1989 Nov;1(2):193–204. [PubMed] [Google Scholar]
  11. Orban P. C., Chui D., Marth J. D. Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6861–6865. doi: 10.1073/pnas.89.15.6861. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI
  12. Pichel J. G., Lakso M., Westphal H. Timing of SV40 oncogene activation by site-specific recombination determines subsequent tumor progression during murine lens development. Oncogene. 1993 Dec;8(12):3333–3342. [PubMed] [Google Scholar]
  13. Sauer B., Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5166–5170. doi: 10.1073/pnas.85.14.5166. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  14. Sauer B., Henderson N. Targeted insertion of exogenous DNA into the eukaryotic genome by the Cre recombinase. New Biol. 1990 May;2(5):441–449. [PubMed] [Google Scholar]
  15. Schwenk F., Baron U., Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res. 1995 Dec 25;23(24):5080–5081. doi: 10.1093/nar/23.24.5080. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  16. Thomas K. R., Capecchi M. R. Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell. 1987 Nov 6;51(3):503–512. doi: 10.1016/0092-8674(87)90646-5. [DOI] [PubMed] [Google Scholar] · DOI · Paper page
  17. Zou Y. R., Müller W., Gu H., Rajewsky K. Cre-loxP-mediated gene replacement: a mouse strain producing humanized antibodies. Curr Biol. 1994 Dec 1;4(12):1099–1103. doi: 10.1016/s0960-9822(00)00248-7. [DOI] [PubMed] [Google Scholar] · DOI

Cited by

Sorted by citations

Authors
Lakso, M., Pichel, J. G., Gorman, J. R., Sauer, B., Okamoto, Y., Lee, E., Alt, F. W., & Westphal, H.
Affiliations
National Institutes of Health (US)
Venue
Proceedings of the National Academy of Sciences
Published
1996-06-11
Volume
93
Issue
12
Pages
5860-5865
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2058172887
Cited by
1,125
References
1
Citations by year
2026: 16 · 2025: 20 · 2024: 31 · 2023: 39 · 2022: 28 · 2021: 29 · 2020: 45 · 2019: 34 · 2018: 43 · 2017: 45 · 2016: 49 · 2015: 40 · 2014: 49 · 2013: 41 · 2012: 53
FWCI
11.42
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
U.S. Public Health Service (A.I. 20047, A.I.31541)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
Cre recombinase, loxP sites, zygote, early mouse embryo, germline transmission, gene targeting, neomycin resistance gene, conditional gene deletion
MeSH terms
Animals, DNA, DNA Nucleotidyltransferases, Eye Neoplasms, Female, Lens, Crystalline, Male, Mice, Transgenic, Viral Proteins, Zygote, Genome, Transgenes, Integrases, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review